SUBSCRIBE
SUBSCRIBE
News   Business

NIR Diagnostics Announces 2008 Second Quarter Results

September 2, 2008 | 
1 min read
CAMPBELLVILLE, ON, Aug. 29 /CNW/ - NIR Diagnostics Inc. (TSX Venture: NID), an innovator in the development of handheld medical diagnostic devices today announced its operational and financial results for the six-month period ended on June 30, 2008.
Earnings
MORE ON THIS TOPIC
Graphic drawing white background
Psychedelics
AbbVie CSO Touts ‘Breakthrough Type Therapy’ Psychedelic as J&J’s Spravato Keeps Growing
February 6, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
Business meeting idea and planning with strategy as a corporate concept with a mechanical wheel bridge as diverse multiracial businesspeople joining together as a symbol for people diversity and success with 3D render elements.
Earnings
Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline
February 6, 2026
 · 
2 min read
 · 
Annalee Armstrong
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO
Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow
February 6, 2026
 · 
5 min read
 · 
Tristan Manalac
FDA Commissioner Dr. Marty Makary delivers remarks after President Donald Trump made an announcement on drug pricing, Tuesday, September 30, 2025, in the Oval Office. (Official White House Photo by Joyce N. Boghosian)
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
 · 
1 min read
 · 
Tristan Manalac